BackgroundsTwo technologies, cardiac contractility modulation (CCM) and subcutaneous implantable cardioverter‐defibrillator (S‐ICD), can be successfully combined and applied to patients with advanced heart failure (HF) with reduced left ventricular ejection fraction (LVEF).Case ReportWe reported a case of a 51‐year‐old man with reduced ejection fraction (LVEF = 33%) and a narrow QRS complex who first underwent simultaneous implantation of CCM and S‐ICD.ConclusionOur case report aimed to reveal that the simultaneous implantation of CCM and S‐ICD could be successfully used in patients with advanced HF, which could significantly improve the clinical symptoms of such patients during one surgery.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.